Stockscreener 앱 받기
1.47
0.00%
0.00
시간 외 거래:
1.48
0.01
+0.68%
Zentalis Pharmaceuticals Inc 주식(ZNTL)의 최신 뉴스
What is the dividend policy of Zentalis Pharmaceuticals Inc. stockBuild a portfolio with strong long-term growth - jammulinksnews.com
How volatile is Zentalis Pharmaceuticals Inc. stock compared to the marketMassive profits - jammulinksnews.com
What are Zentalis Pharmaceuticals Inc. company’s key revenue driversUnbelievable profit margins - jammulinksnews.com
What catalysts could drive Zentalis Pharmaceuticals Inc. stock higher in 2025Maximize your gains with professional insights - jammulinksnews.com
Will Zentalis Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsQuick Profit Idea Stream - Newser
Sectors Driving Future Growth for Zentalis Pharmaceuticals Inc. StockFree Access to Community - Newser
What are analysts’ price targets for Zentalis Pharmaceuticals Inc. in the next 12 monthsAchieve remarkable returns with smart investing - jammulinksnews.com
When is Zentalis Pharmaceuticals Inc. stock expected to show significant growthBoost your wealth with consistent growth stocks - jammulinksnews.com
What makes Zentalis Pharmaceuticals Inc. stock price move sharplyConsistent High Return Strategy - Newser
What drives Zentalis Pharmaceuticals Inc. stock priceFree Technical Analysis Support - PrintWeekIndia
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) is favoured by institutional owners who hold 59% of the company - Yahoo Finance
Is Zentalis Pharmaceuticals Inc. a good long term investmentFree Technical Analysis Support - Autocar Professional
What analysts say about Zentalis Pharmaceuticals Inc. stockFree Stock Selection - Autocar Professional
Zentalis Pharmaceuticals Inc. Stock Analysis and ForecastAccelerated capital growth - Autocar Professional
Why Zentalis Pharmaceuticals Inc. stock attracts strong analyst attentionPrecision Entry Strategy - Newser
How Zentalis Pharmaceuticals Inc. stock performs during market volatilityDaily Swing Candidates - Newser
Insider Stock Buyers At Zentalis Pharmaceuticals Recouped Some Losses This Week - simplywall.st
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Wealth Enhancement Advisory Services LLC Purchases 33,958 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - TradingView
Zentalis Grants $1.19 Per Share Stock Options Package Under Nasdaq Compliance Rules - Stock Titan
Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) dropped from Russell Small Cap Completeness Index - MarketScreener
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting - Investing.com
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of “Hold” from Brokerages - Defense World
Wealth Enhancement Advisory Services LLC Raises Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Sold by Bank of America Corp DE - Defense World
Squarepoint Ops LLC Reduces Stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World
Ameriprise Financial Inc. Purchases New Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World
Zentalis Pharmaceuticals Announces Azenosertib Fast Track Designation and Virtual Corporate Event to Present Updated Data from Azenosertib Clinical Studies - The Globe and Mail
ProShare Advisors LLC Lowers Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World
Why Did Zentalis Pharmaceuticals Inc. (ZNTL) Plunge 11.33%? - AInvest
Nuveen Asset Management LLC Has $1.94 Million Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World
Deutsche Bank AG Grows Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World
Two Sigma Investments LP Sells 291,801 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ZNTL Stock News - GuruFocus
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Zentalis Expands Cancer Research Team: 137K Share Options Granted to Key New Hires - Stock Titan
Zentalis Pharmaceuticals Presents Promising Study Results at ASCO - TipRanks
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Acquired by Millennium Management LLC - Defense World
0.97%
0.22%
자본화:
|
볼륨(24시간):